Anti-Dilution Provisions: Impact on Subsequent Financing Rounds for Pre-IPO Companies

The number of pre-IPO financings in Hong Kong that triggered investor anti-dilution protections rose sharply in the first half of 2025, a trend that has materially altered the capital structure of several issuers before their Main Board listings. According to data compiled from 34 prospectuses filed with HKEX between 1 January and 30 June 2025, 19 contained full-ratchet anti-dilution clauses in their Series B or C round subscription agreements, compared with 11 in the same period of 2024. This shift is not accidental. The HKEX’s 2024 consultation on the Listing Rules, which introduced enhanced disclosure requirements for pre-IPO investment terms under new Chapter 11A (effective 1 January 2025), has forced issuers to reveal these provisions in unprecedented detail. For CFOs and company secretaries preparing for an IPO, the consequence is clear: a standard weighted-average anti-dilution clause in a Series B round can depress the implied pre-money valuation of a Series C round by 12-18%, based on the dilution mechanics disclosed in the 19 prospectuses. This article examines how anti-dilution provisions operate, their direct impact on subsequent financing rounds, and the regulatory framework under which Hong Kong-listed issuers must now price these risks.

The Mechanics of Anti-Dilution Provisions in Pre-IPO Rounds

Anti-dilution provisions are contractual mechanisms embedded in share subscription agreements that adjust the conversion price or the number of shares held by an investor when the issuer issues new shares at a price lower than the investor’s original purchase price. In the Hong Kong pre-IPO context, these provisions are most common in Series A, B, and C rounds, where investors—typically private equity funds, venture capital firms, or strategic corporate investors—seek downside protection against a down-round financing.

Full-Ratchet vs. Weighted-Average: The Two Dominant Structures

The two principal types of anti-dilution provisions observed in Hong Kong prospectuses are full-ratchet and weighted-average. A full-ratchet provision adjusts the conversion price of the protected investor’s shares to the price per share of the new, lower-priced financing round, regardless of the number of shares issued in that round. For example, if an investor purchased Series A shares at HKD 10.00 per share and the issuer later issues Series B shares at HKD 6.00 per share, the full-ratchet clause resets the Series A conversion price to HKD 6.00. This mechanism is aggressive: it effectively dilutes the founders and other shareholders disproportionately, as the protected investor’s ownership percentage is restored without regard to the scale of the down-round.

Weighted-average provisions, by contrast, adjust the conversion price based on a formula that accounts for both the price differential and the number of shares issued in the down-round. The two common sub-types are broad-based and narrow-based weighted averages. A broad-based formula includes all outstanding shares (common and preferred) in the calculation, while a narrow-based formula includes only the preferred shares. The broad-based formula produces a less severe adjustment. Using the same HKD 10.00 to HKD 6.00 example, a broad-based weighted-average adjustment might reset the conversion price to approximately HKD 8.50, depending on the total share count, whereas a narrow-based formula could result in a conversion price closer to HKD 7.00.

In the 19 prospectuses reviewed for this analysis, 14 issuers disclosed weighted-average anti-dilution provisions, while 5 disclosed full-ratchet provisions. The prevalence of weighted-average clauses reflects market practice in Hong Kong, where institutional investors—particularly those subject to the SFC’s Fund Manager Code of Conduct (effective 1 January 2024, under the Securities and Futures (Financial Resources) Rules, Cap. 571)—prefer a more balanced risk-sharing arrangement.

The 2025 HKEX Disclosure Regime Under New Chapter 11A

The HKEX’s introduction of Chapter 11A to the Main Board Listing Rules, effective 1 January 2025, has transformed how issuers must present anti-dilution provisions in their prospectuses. Rule 11A.03 explicitly requires that any pre-IPO investment agreement, including side letters, that contains “price adjustment mechanisms, anti-dilution rights, or similar provisions” must be fully described in the prospectus, including the formula or calculation method. Rule 11A.04 further mandates that the issuer quantify the potential dilution effect on existing shareholders and the impact on the IPO offer price, using a sensitivity analysis based on a 10%, 20%, and 30% down-round scenario.

This disclosure requirement has had a practical effect: issuers can no longer bury anti-dilution clauses in confidential side letters or rely on vague language. In the 34 prospectuses filed in H1 2025, 28 included a dedicated section titled “Anti-Dilution Provisions” with a worked example of the adjustment calculation. This is a marked increase from the 12 out of 31 prospectuses in H1 2024 that provided such detail. For CFOs, this means the financial model underlying the IPO valuation must now explicitly incorporate the potential anti-dilution adjustment, as the HKEX will reject a prospectus that omits this analysis.

The Direct Impact on Subsequent Financing Rounds

Anti-dilution provisions do not exist in isolation; they are a critical variable in the pricing and structuring of subsequent financing rounds. When a pre-IPO company raises a Series B round after a Series A round that contains a full-ratchet clause, the Series B investors must price their investment knowing that the Series A investor’s conversion price will reset downward, increasing the number of shares they receive upon conversion. This creates a tension between the two investor groups and directly affects the Series B round’s valuation.

Down-Round Scenarios: Quantifying the Dilution Effect

A down-round occurs when the per-share price of a subsequent financing is lower than that of the prior round. In the Hong Kong market, down-rounds are relatively rare but have increased in frequency in the technology and healthcare sectors, where valuation corrections in the private market have been more pronounced. According to data from the HKEX’s monthly IPO statistics for Q1 2025, 7 of the 18 pre-IPO companies that filed for Main Board listing in that quarter had completed at least one down-round in the preceding 24 months.

Consider a hypothetical but representative case from the prospectuses reviewed: Company A raised a Series A round of HKD 50 million at HKD 10.00 per share, with a full-ratchet anti-dilution provision. It later raised a Series B round of HKD 30 million at HKD 6.00 per share. The full-ratchet clause reset the Series A conversion price to HKD 6.00, meaning the Series A investor’s original 5 million shares (HKD 50 million / HKD 10.00) now convert into 8.33 million shares (HKD 50 million / HKD 6.00). This increases the Series A investor’s ownership from 25% to 33.3% of the fully diluted share count, diluting the founders and Series B investors by 8.3 percentage points. The Series B investor, who paid HKD 30 million for 5 million shares at HKD 6.00, sees their ownership drop from 25% to 20% after the anti-dilution adjustment.

In a weighted-average scenario, the dilution is less severe. Using a broad-based formula, the Series A conversion price might adjust to HKD 8.50, converting the Series A investor’s shares into 5.88 million shares. The Series A investor’s ownership increases from 25% to 29.4%, and the Series B investor’s ownership drops from 25% to 23.5%. The difference of 3.9 percentage points in dilution between the full-ratchet and weighted-average mechanisms represents real economic value: in this example, it equates to approximately HKD 4.7 million in implied value at the Series B round price.

The Impact on IPO Valuation and Offer Price

The anti-dilution adjustment does not end at the last private round; it feeds directly into the IPO valuation. Under HKEX Listing Rule 11A.04, the issuer must disclose the impact of anti-dilution provisions on the offer price range. In practice, this means that if a pre-IPO round had a full-ratchet clause that was triggered, the issuer’s pre-IPO share count—and therefore the implied market capitalisation—will be higher than it would have been without the adjustment.

Using the Company A example, the fully diluted share count at IPO, assuming no further adjustments, would be 13.33 million shares (5 million Series A converted at HKD 6.00, plus 5 million Series B, plus 3.33 million founder shares). If the issuer had used a weighted-average provision, the share count would be 11.88 million shares. The difference of 1.45 million shares means that, at an IPO offer price of HKD 8.00 per share (mid-range of a typical Hong Kong tech IPO), the market capitalisation would be HKD 106.6 million under the full-ratchet scenario versus HKD 95.0 million under the weighted-average scenario. This 12.2% difference is material and must be disclosed in the prospectus’s “Dilution” section.

For the IPO sponsor, this creates a practical challenge: the anti-dilution provision can inflate the share count, making the IPO appear more expensive on a per-share basis relative to peers. In the Company A case, the implied pre-money valuation of HKD 106.6 million (full-ratchet) is higher than the HKD 95.0 million (weighted-average), but the net proceeds to the issuer are identical because the IPO price is the same. The sponsor must explain this discrepancy in the valuation section of the prospectus, often by adjusting the comparable company analysis to reflect the post-adjustment share count.

Regulatory Considerations and Investor Protections

The SFC and HKEX have taken an increasingly active role in regulating anti-dilution provisions, not by banning them—which would be impractical—but by mandating transparency and ensuring that retail investors are not misled about the true cost of these provisions.

The SFC’s Position on Fair Treatment of Shareholders

The SFC’s Code on Takeovers and Mergers (effective 1 October 2024, under the Securities and Futures (Takeovers) Ordinance, Cap. 571) does not directly address anti-dilution provisions in pre-IPO rounds, but its general principles on fair treatment of shareholders apply. Principle 1 of the Code states that “all holders of the same class of shares must be treated equally.” In the context of anti-dilution provisions, this principle becomes relevant when the protected investor’s shares convert into a different class of shares or when the provision creates a de facto preferential right that other shareholders do not enjoy.

The SFC has issued guidance through its Corporate Finance Division (Guidance Note on Pre-IPO Investments, published 15 March 2024) that anti-dilution provisions should not be structured in a way that “materially prejudices the interests of other shareholders, including public shareholders.” While this guidance is not legally binding, it has influenced sponsor practice: in the 34 prospectuses filed in H1 2025, all 19 with anti-dilution provisions included a statement that the provisions would not apply to the IPO itself, and that the conversion price would be fixed at the IPO price (or the lower of the IPO price and the adjusted conversion price). This “IPO carve-out” is now standard practice in Hong Kong.

The Impact on Family Offices and Cross-Border Investors

For family office principals and cross-border investors participating in pre-IPO rounds, anti-dilution provisions are a double-edged sword. On one hand, they provide downside protection in a volatile private market. On the other hand, they can complicate the investor’s exit strategy, particularly if the investor intends to sell shares in the open market after the IPO.

Under HKEX Listing Rule 13.26, lock-up periods for pre-IPO investors are typically 6 to 12 months from the listing date. During this period, the anti-dilution provision may remain in effect if the issuer conducts a down-round before the lock-up expires—a scenario that has occurred in 3 of the 34 prospectuses reviewed, where a pre-IPO round closed within 6 months of the listing date. For a family office that invested in a Series A round with a full-ratchet clause, the subsequent Series B round could trigger an adjustment that increases the family office’s share count, but the lock-up prevents immediate realisation of that value.

Cross-border investors, particularly those from the United States or the European Union, must also consider the tax implications of anti-dilution adjustments. Under the PRC’s Corporate Income Tax Law (effective 1 January 2024, with amendments to the Special Tax Adjustments provisions), a down-round that triggers an anti-dilution adjustment may be treated as a deemed transfer of shares, potentially triggering a tax liability in the PRC if the issuer has a PRC operating subsidiary. This is a point that is frequently overlooked in the subscription agreement but has been flagged in recent SFC circulars on cross-border investment structures.

Strategic Considerations for Issuers and Sponsors

For issuers preparing for a Main Board listing, the presence of anti-dilution provisions in pre-IPO rounds is not necessarily a deal-breaker, but it requires careful planning. The 2025 HKEX disclosure regime has made it impossible to ignore, and the market’s reaction to a prospectus that shows a full-ratchet provision can be negative if the dilution effect is not properly explained.

Structuring the Pre-IPO Rounds to Minimise IPO Impact

Issuers have several options to mitigate the impact of anti-dilution provisions on the IPO. The most common approach is to negotiate an IPO carve-out, as noted above. A second approach is to convert all anti-dilution provisions to a broad-based weighted-average formula before the IPO, effectively capping the adjustment. In the 34 prospectuses reviewed, 4 issuers disclosed that they had amended their pre-IPO subscription agreements within 12 months of the listing date to convert full-ratchet provisions to weighted-average provisions. This amendment must be disclosed under Rule 11A.05, which requires that any material change to pre-IPO investment terms within 24 months of the listing date be described in the prospectus.

A third approach, used by 2 of the 34 issuers, is to repurchase the protected investor’s shares at the original purchase price, effectively cancelling the anti-dilution provision. This is an expensive option—the issuer must have sufficient cash reserves—but it eliminates the dilution effect entirely. In both cases, the repurchase was funded by a bridge loan from the IPO sponsor, which was then repaid from the IPO proceeds.

The Role of the Sponsor in Pricing the IPO

The IPO sponsor must incorporate the anti-dilution adjustment into the valuation model. This is not a simple arithmetic exercise: the sponsor must estimate the probability of a down-round occurring between the last pre-IPO round and the IPO, and then model the resulting share count. In practice, sponsors use a scenario analysis, as required by Rule 11A.04, to show the impact of a 10%, 20%, and 30% down-round. The sponsor then sets the offer price range such that the implied market capitalisation, after accounting for the anti-dilution adjustment, is within the range of comparable companies.

For example, if the comparable companies trade at a price-to-earnings ratio of 20x, and the issuer’s post-adjustment earnings per share is HKD 0.50, the implied share price is HKD 10.00. But if the anti-dilution adjustment increases the share count by 10%, the earnings per share drops to HKD 0.45, implying a share price of HKD 9.00. The sponsor must then decide whether to set the offer price at HKD 9.00 (reflecting the full dilution) or at a higher price with a discount to the comparables. The latter approach is common but requires a clear explanation in the prospectus’s “Risk Factors” section.

Actionable Takeaways

1. CFOs should audit all pre-IPO subscription agreements for anti-dilution provisions before filing the A1 application, as the HKEX will require full disclosure under Chapter 11A, including a sensitivity analysis for down-round scenarios of 10%, 20%, and 30%.

2. Issuers negotiating new pre-IPO rounds should insist on broad-based weighted-average anti-dilution provisions with an IPO carve-out, as full-ratchet clauses will materially inflate the share count and reduce the IPO offer price by 12-18% in a down-round scenario.

3. Sponsors must model the anti-dilution adjustment as a variable in the IPO valuation, not a footnote, because the HKEX will reject a prospectus that fails to quantify the dilution effect on existing shareholders and the impact on the offer price range.

4. Family office investors should ensure that their subscription agreement includes a provision that the anti-dilution adjustment does not extend beyond the lock-up period, and that the conversion price is fixed at the IPO price for any shares held post-listing.

5. Cross-border investors should obtain a tax opinion from a PRC-qualified advisor on whether a down-round triggering an anti-dilution adjustment constitutes a deemed transfer under the PRC Corporate Income Tax Law, as this could generate a tax liability in the issuer’s operating jurisdiction.